GHFT - Prescribing tolvaptan for autosomal dominant polycystic kidney disease

GHFT - Prescribing tolvaptan for autosomal dominant polycystic kidney disease featured image
  • Acute
  • Acute > Clinical Support
  • Acute > Clinical Support > Pharmacy
  • Acute > Medicine
  • Acute > Medicine > General Internal Medicine
  • Leadership and Management
  • Leadership and Management > Quality and Performance
  • Leadership and Management > Quality and Performance > QI
  • Campaigns
  • Campaigns > #FabChange19
22 November 2024

#FabRCNFoundation - come and see us at GIANT

22 November 2024

Hospital Discharge - Inclusion Matters

Menu
This website uses cookies to ensure you get the best experience on our website.
Manage Preferences
Download acrobat reader